Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart ventilator may help burn patients breathe easier

NCT ID NCT07674563

Disease control Sponsor: Ukrainian Society of Regional Anesthesia and Pain Therapy Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study compares two ways of using breathing machines in adults with severe burns (covering 20% or more of the body). One method, called Adaptive Support Ventilation (ASV), automatically adjusts the machine's settings to the patient's needs. The other is standard lung-protective ventilation. The goal is to see if ASV helps patients spend more days off the ventilator and have fewer complications. Participants are randomly assigned to one of the two methods.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Adaptive Support Ventilation (ASV) device
What this could lead to
If ASV proves better, it could reduce time on ventilators and complications for severely burned patients, improving survival and recovery.
What could go wrong
This is a single, relatively small trial (100 patients) in a specific population. ASV may not show clear benefits over standard care, and results may not apply to all burn centers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older. * Thermal burn injury involving ≥20% total body surface area (TBSA). * Requirement for invasive mechanical ventilation expected to exceed 24 hours. * Admission to a participating intensive care unit within 48 hours of injury. * Burn injury resulting from conventional flame burns, explosion-related burns, drone-related burns, or thermobaric blast burns. * Written informed consent provided by the patient or a legally authorized representative. Exclusion Criteria: * Age younger than 18 years. * Pregnancy or breastfeeding. * Pre-existing chronic respiratory failure requiring home oxygen therapy or long-term mechanical ventilation. * Severe chronic obstructive pulmonary disease (COPD GOLD IV) or other end-stage pulmonary disease. * Extracorporeal membrane oxygenation (ECMO) at the time of enrollment. * Severe traumatic brain injury requiring controlled hyperventilation. * Expected death within 24 hours of ICU admission. * Do-not-resuscitate (DNR) order or limitations of life-sustaining treatment. * Previous enrollment in the current study. * Participation in another interventional trial that may interfere with study outcomes.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Burn are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

burn

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Burn Combat-related burn injury Critical care, intensive care ICU Icu hospitalization Mechanical ventilation Mechanical ventilation complication Military activity

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.